Literature DB >> 8447162

Principles of selective inactivation of viral genome. VIII. The influence of beta-propiolactone on immunogenic and protective activities of influenza virus.

E I Budowsky1, S F Shenderovich.   

Abstract

The influence of beta-propiolactone action on the immunogenic and protective activity of the influenza virus A/WSN/33 (H1N1) has been studied. The production of antibodies against virion surface antigens in mice immunized intramuscularly by the modified virus was enhanced with the increase of inoculating dose from 6 x 10(7) to 1.5 x 10(8) viral particles per animal. The immunizing dose of 6 x 10(7) produced complete protection of immunized animals against a lethal challenge of A/WSN/33 virus. The inhibition of virus reproduction in animal lungs was increased with the increase of the virus immunizing dose up to 6 x 10(8). At a constant dose the inhibition of virus reproduction decreases with the increase of the virus modification extent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8447162     DOI: 10.1016/0264-410x(93)90197-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Validation of normal human bronchial epithelial cells as a model for influenza A infections in human distal trachea.

Authors:  A Sally Davis; Daniel S Chertow; Jenna E Moyer; Jon Suzich; Aline Sandouk; David W Dorward; Carolea Logun; James H Shelhamer; Jeffery K Taubenberger
Journal:  J Histochem Cytochem       Date:  2015-01-20       Impact factor: 2.479

Review 2.  Development of stable influenza vaccine powder formulations: challenges and possibilities.

Authors:  J-P Amorij; A Huckriede; J Wilschut; H W Frijlink; W L J Hinrichs
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

3.  Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicity.

Authors:  Yossef Raviv; Robert Blumenthal; S Mark Tompkins; Jennifer Humberd; Robert J Hogan; Mathias Viard
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

4.  Evaluation of Immunoreactivity and Protection Efficacy of Seneca Valley Virus Inactivated Vaccine in Finishing Pigs Based on Screening of Inactivated Agents and Adjuvants.

Authors:  Wenqiang Liu; Xiangmin Li; Huawei Zhang; Genxi Hao; Xianfei Shang; Huilan Wang; Huanchun Chen; Ping Qian
Journal:  Vaccines (Basel)       Date:  2022-04-18

5.  Surface modifications of influenza proteins upon virus inactivation by β-propiolactone.

Authors:  Yi-Min She; Keding Cheng; Aaron Farnsworth; Xuguang Li; Terry D Cyr
Journal:  Proteomics       Date:  2013-12       Impact factor: 3.984

6.  Large scale production and characterization of SARS-CoV-2 whole antigen for serological test development.

Authors:  Helena Cerutti; Veronica Ricci; Giulia Tesi; Claudia Soldatini; Marinunzia Castria; Marco Natale Vaccaro; Stefania Tornesi; Simona Toppi; Silvana Verdiani; Alessandra Brogi
Journal:  J Clin Lab Anal       Date:  2021-02-19       Impact factor: 3.124

7.  Propagation, Inactivation, and Safety Testing of SARS-CoV-2.

Authors:  Alexander S Jureka; Jesus A Silvas; Christopher F Basler
Journal:  Viruses       Date:  2020-06-06       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.